Petrus Trust Company, Lta Atri Cure, Inc. Transaction History
Petrus Trust Company, Lta
- $949 Million
- Q3 2024
A detailed history of Petrus Trust Company, Lta transactions in Atri Cure, Inc. stock. As of the latest transaction made, Petrus Trust Company, Lta holds 7,560 shares of ATRC stock, worth $280,173. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,560Holding current value
$280,173% of portfolio
0.02%Shares
4 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$173 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$171 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$147 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$105 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$103 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.72B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...